<DOC>
	<DOC>NCT01148186</DOC>
	<brief_summary>An educational intervention targeting community-dwelling older adults will lead to a reduction in potentially inappropriate prescriptions (e.g. benzodiazepines, oxybutynin). Cessation of potentially inappropriate medications (e.g. benzodiazepines, oxybutynin)will lead to improved cognitive outcomes in older adults.</brief_summary>
	<brief_title>An Intervention Study to Reduce the Use and Impact of Potentially Inappropriate Medications Among Older Adults</brief_title>
	<detailed_description>This study tests the effectiveness of a knowledge transfer tool for empowering patients to engage in collaborative discontinuation of potentially inappropriate medication with their pharmacist and/or physician</detailed_description>
	<criteria>65 year old human adults who fill a prescription for at least 5 medications community dwelling chronic use (3 months or longer) of at least one potentially inappropriate medication (e.g. benzodiazepine, oxybutynin) patients with severe mental illness, dementia and epilepsy concomitant consumption of any other antipsychotic medication (including lithium, olanzapine, clozapine, quetiapine, risperidone, haloperidol etc.) concomitant consumption of any antiepileptic (including carbamazepine, valproate, gabapentin, lamotrigine, topiramate, oxcarbazepine etc.) concomitant consumption of a cholinesterase inhibitor or memantine</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Polypharmacy</keyword>
	<keyword>Benzodiazepine use</keyword>
	<keyword>Oxybutynin use</keyword>
	<keyword>cognition disorders/drug therapy</keyword>
	<keyword>incontinence</keyword>
</DOC>